Raise the Line
Osmosis from Elsevier
All episodes
Best episodes
Top 10 Raise the Line Episodes
Goodpods has curated a list of the 10 best Raise the Line episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to Raise the Line for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite Raise the Line episode by adding your comments to the episode page.
Navigating Change in the U.S. Healthcare System - Susan Dentzer, President & CEO of America’s Physician Groups
Raise the Line
12/19/22 • 39 min
We welcome one of the nation's most respected health and health policy thought leaders to Raise the Line on this episode. Susan Dentzer’s remarkable career includes many years of reporting on healthcare for major national news outlets, being a senior policy adviser to the Robert Wood Johnson Foundation and serving as a board leader in medical education and health system delivery, just to name a few of her contributions. Earlier this year, Ms. Dentzer was appointed president and CEO of America's Physician Groups, an organization representing more than 350 physician groups providing coordinated, value-based healthcare for more than ninety million patients nationwide. She's also currently board chair of Research America, which advocates on behalf of biomedical and health-related research and innovation. Tune in to this elucidating discussion with host Shiv Gaglani that delves into what the pandemic revealed about value-based care and virtual care; what is helping to lessen clinician burnout; surprising views among medical students on the use of tech in healthcare; what is at the root of the public’s mistrust of science, and much more. “The reality of healthcare is very complicated. What I would make a plea for is that we all try to engage in developing a greater understanding of the issues, as opposed to seeing them through a narrow lens.”
Mentioned in this episode:
https://www.apg.org/
https://www.researchamerica.org/
If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
A Reservoir of Hope Drives Research Into a Rare Brain Disorder - Scott Reich, Co-Founder of Believe in a Cure
Raise the Line
12/15/22 • 35 min
“There's a reservoir of hope, energy and optimism many of us have that we may not know about until we're really tested,” says attorney and author Scott Reich. The heavy test he and his wife Ilissa have endured for the past three years started when their infant son Eli was diagnosed with a rare brain disorder called FOXG1 Syndrome which causes severe seizures and impedes normal movement, speech and sleep, among other problems. Scott vividly recalls the moment when Eli’s doctor explained there was no hope for treatments or a cure. “I just felt an instantaneous gravitational pull that despite the intense emotion that overtook us in the doctor's office, we were going to do something about it.” That “something” includes starting the nonprofit foundation Believe in a Cure which is currently funding over fifty research and development projects worldwide focused on this pernicious disorder. Join us for this enlightening conversation with host Shiv Gaglani to learn about the multi-pronged strategy scientists are pursuing to overcome the mutation in this so-called master gene, the promising results emerging from preclinical programs and the supportive global community Believe in a Cure has helped create for the hundreds of other families fighting the same battle.
Mentioned in this episode: https://www.webelieveinacure.org
If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
A Hypothesis-Agnostic Approach to Accelerating Drug Discovery - Dr. Chris Gibson, Co-Founder and CEO of Recursion
Raise the Line
12/14/22 • 31 min
“I’m currently sitting 100 feet away from a giant lab full of robots where we can do up to 2.2 million experiments a week,” says Dr. Chris Gibson, the Co-Founder and CEO of Recursion, a company whose mission is to create a more efficient path to drug discovery. You are going to hear a lot of mind-boggling numbers from Chris in today’s Raise the Line episode, but they all boil down to this: advances in genetics, computing, artificial intelligence, mRNA capability and other technologies are all converging to accelerate the testing of drugs at an incredible pace. This is particularly good news for people with rare diseases who are often in a race against time for development of therapies. Although only founded nine years ago, Recursion already has four programs in clinical trials. A key factor in this success is a bold departure from the traditional hypothesis-based approach to science driven by lab failures Chris experienced while earning his MD-PhD. Once he and his colleagues cast aside their bias about what was driving the disease in question, they achieved success in animal testing. “We just modeled the genetic loss of function because we knew that incontrovertibly to be true, and then asked the cells what was actually driving the disease and what could make it better.” Don’t miss this fascinating look at reengineering drug discovery through gene mapping, training neural networks and other leading-edge technology.
Mentioned in this episode: https://www.recursion.com/
If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
You might think improving healthcare quality is largely in the hands of the clinicians providing the care, but much of this challenging work is actually done behind the scenes by professionals who lead quality reviews, institute new protocols for safer care and focus on performance improvement, among many other efforts. “We are on a journey to really change the perception of what quality is. We want to make it more prospective and actually solve problems for patients and the healthcare workforce,” says Stephanie Mercado, CEO and Executive Director of the National Association for Healthcare Quality. On this episode of Raise the Line, we get an inside look at this critically important function in healthcare, and at the Healthcare Quality Workforce ReportNAHQ recently released that recognizes the field’s progress, but also outlines places for improvement. “The areas most important for the future of healthcare are things where the workforce is performing at lower ends of the competency spectrum. Those include health data analytics, change management and payment models. So, we have a lot of work to do.” Check out this revealing conversation with host Michael Carrese to learn what the future holds for quality professionals as healthcare challenges mount.
Mentioned in this episode: https://nahq.org/
If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
12/01/22 • 43 min
“You know, it's easy to say that default answer that everything's okay, but it's really not. She's lost a lot of her vision, she's got hundreds of seizures at night, and she's having difficulty walking,” shares Luke Rosen about his eight-year-old daughter Susannah. She was born with KIF1A-associated neurological disorder -- or KAND -- a rare, degenerative genetic disease for which there is currently no cure or treatment. On this episode of Raise the Line, Luke talks about how he and his wife Sally summoned the strength to move beyond their family’s own challenges to create KIF1A.org which is working to rapidly discover a treatment for all patients and families affected by this devastating disorder, but to also create a supportive community. “Five years later, we have approximately four hundred families around the world that we've identified and there's not one family I know that doesn't play a significant role in what we do.” Thanks to that global community and partnerships with the Chan Zuckerberg Initiative, Columbia University, the n-Lorem Foundation, the Jackson Laboratory and many other organizations, there’s reason to be hopeful, as Luke shares with host Shiv Gaglani. “Susannah has been fortunate enough to just have started an experimental treatment. We really are on the brink of several things for, hopefully, the entire community.” Tune in for a candid and moving look at how families and supportive scientists and healthcare providers are mobilizing to fight back against a rare and pernicious threat to their children.
Mentioned in this episode: https://www.kif1a.org/
If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
Solving the Rare Disease Equation - Dr. Alaa Hamed, Global Head of Medical Affairs, Rare Diseases at Sanofi
Raise the Line
11/30/22 • 24 min
As we continue our focus on rare diseases on Raise the Line, we’re delighted to be joined by Dr. Alaa Hamed, Global Head of Medical Affairs, Rare Diseases at Sanofi, one of the leading pharmaceutical companies in the world. Although most well known for their focus on lysosomal storage disorders including Gaucher and Pompe disease, Dr. Hamed and his team at Sanofi are also working in adjacent disease spaces depending on the systems affected. “For example, the lysosome in Pompe disease affects the neuromuscular tissues, so we have a neuromuscular disorder interest as well.” In their discussion, Dr. Hamed and host Shiv Gaglani also touch on the efforts Sanofi is making to shorten the diagnostic odyssey for rare disease patients, including building more disease awareness and greater global infrastructure. “From the inception, we thought that having universal access is a key part of the rare disease equation.” You’ll also learn about the challenges of drug development, the importance of maintaining policy incentives to focus on rare diseases, and where innovation is needed most to advance outcomes for patients.
Mentioned in this episode: https://www.sanofi.com/
If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
11/29/22 • 28 min
“Imaging has really become the tip of the spear of the patient journey,” says Daniel Arnold, CEO of Medality. In order to train future radiologists in this critically important and complex specialty, and keep current practitioners on top of their game, Arnold and his team are on a mission to transform the way radiologists learn by offering an online solution that mimics practicing radiology in the field. “Our goal is to make it easy for radiologists to learn a new subspecialty in just five minutes per day.” In his conversation with host Shiv Gaglani, Arnold touches on how Medality (formerly MRI Online) is connecting radiology practices with people who have the skills they need most. The two also discuss the importance of getting imaging diagnoses correct the first time, why radiologists can't just rely on what they learned in residency and fellowship, and the impact of artificial intelligence and other technological advances in the field. “Being a part of the puzzle around how we disseminate new lifesaving technologies is what really motivates us and gets us excited.”
Mentioned in this episode: https://mrionline.com/
If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
“One of the reasons I really wanted to be at Walmart is that you're touching people that truly have a need,” says Dr. John Wigneswaran, the retail giant’s Chief Medical Officer. And giant is not an overstatement. 150 million Americans visit a Walmart every week, and there is a store within ten miles of 90% of the U.S. population. In terms of healthcare, there are roughly 5,000 Walmart pharmacies, 4,000 of which are in medically underserved areas. Walmart visitors also have access to primary and urgent care, labs, x-ray and diagnostics, behavioral health, dental, optometry and hearing services. So, clearly, the company is in a unique position to make a big impact in the healthcare space whatever they choose to do. One of their most recent choices is to boost the participation of rural and underserved communities in clinical research, which Dr. Wigneswaran sees as an extension of their existing mission. “Ultimately, what we're trying to do to is drive safer, high quality and equitable care, and research is just one of the levers,” he tells host Shiv Gaglani. Tune in to learn about the evolution of a growing player in America’s healthcare system which could include initiatives in diabetes, nutrition education, wound care and HIV.
Mentioned in this episode: Walmart Health and Wellness
If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
Having the ability to manage uncertainty is helpful in all professions, but perhaps especially so in medicine where uncertainty abounds and the stakes for managing it are high. Despite that, medical students receive little training in this area, something which our guest today, Dr. Jenny Moffett of RCSI University of Medicine and Health Sciences in Dublin, is working to change. “There are approaches to uncertainty that can be learned. We can change our perspective and perceptions around uncertainty, stepping away from always viewing it as something aversive, but perhaps maybe looking at it with a little bit more curiosity and openness, and that's definitely a transformation that faculty can make,” says Dr. Moffett, the program director of the Postgraduate Diploma in Health Professions Education. In addition to a perspective shift, Moffett also believes providers should develop skills to talk about uncertainty with patients in an open and honest way. “Clinicians can say, I'm on this journey with you. I don't have all of the answers, but we have paths, we have options, and I'll be there with you as we work them out.” Join host Caleb Furnas as he explores Dr. Moffett’s fascinating work in this area which includes development of an immersive puzzle game that encourages students to address complex, ambiguous, and unpredictable issues.
Mentioned in this episode:
RCSI University of Medicine and Health Sciences
If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
Show more best episodes
Show more best episodes
FAQ
How many episodes does Raise the Line have?
Raise the Line currently has 523 episodes available.
What topics does Raise the Line cover?
The podcast is about Health & Fitness, Cme, Interview, Nursing, Medicine, Podcast, Podcasts, Nursing School, Edtech, Covid-19, Education, Coronavirus, Health, Medical Education, Artificial Intelligence, Machine Learning, Virus, Pandemic and Healthcare.
What is the most popular episode on Raise the Line?
The episode title 'Unraveling the Mysteries of Post-Exertional Malaise: Special Series from The Cohen Center for Recovery from Complex Chronic Illnesses at Mount Sinai' is the most popular.
What is the average episode length on Raise the Line?
The average episode length on Raise the Line is 28 minutes.
How often are episodes of Raise the Line released?
Episodes of Raise the Line are typically released every 2 days.
When was the first episode of Raise the Line?
The first episode of Raise the Line was released on Apr 15, 2020.
Show more FAQ
Show more FAQ